Founded more than 30 years ago, CliniSys Group provides clinical laboratory management solutions used in 45 percent of the United Kingdom’s NHS Trust and laboratories. CliniSys has approximately 450 diagnostics IT professionals who deploy the company’s solutions in several languages in thousands of labs across 23 countries. In addition, CliniSys has a leading order communications and results reporting system with a large deployment footprint in the NHS.
The services CliniSys provides are vital for surveilling and sharing case reports with public health agencies, particularly in the wake of the Covid-19 pandemic. Since the pandemic began, CliniSys customers have called on the company to set up entirely new labs in previously unheard-of timeframes — sometimes in less than 24 hours.
Because of the increased time pressure, it’s imperative that CliniSys solutions be reliable, secure, and easy to use so that labs across the UK can accurately report testing and case data. Having the Rhapsody by Lyniate Integration Engine embedded into their products has helped CliniSys meet this demand.
“While CliniSys has always supported our customers with the introduction of new diagnostic equipment into the laboratories, you can appreciate in the current climate, these requests have increased in volume and the timeframes for the new equipment integration has significantly reduced,” said Darren Markham, product specialist at CliniSys.
Supporting Nightingale Hospitals and National Pathology Exchange
CliniSys has been involved in several Covid-related activities initiated by the UK government, including the establishment of Nightingale Hospitals and a recent mandate that labs use the National Pathology Exchange (NPEx) for Covid testing and reporting.
In March 2020, the National Health System (NHS) began setting up seven temporary critical care facilities called Nightingale Hospitals. Several of the Nightingale Hospitals are using CliniSys to configure their laboratory information management systems (LIMS). For instance, the Birmingham Nightingale uses the CliniSys ICE product for ordering tests and reporting results.
CliniSys is also assisting with lab connectivity through NPEx — a hub that connects all UK labs together so that test requests and pathology results can be sent digitally from any lab to any lab in a matter of seconds. Prior to Covid, lab participation in NPEx was optional, but in March 2020, government leaders mandated that every lab doing Covid tests must use NPEx to exchange data in the fastest possible timeframe. NPEx is using CliniSys solutions embedded with Rhapsody to achieve this.
Data exchange through the NPEx is important because it allows test orders to be distributed to labs that have the most capacity to perform the test.
“With Covid the expectation is that testing will significantly increase, so this gives us an opportunity to distribute that demand across a number of laboratories where capacity may be available,” Markham said.
Download the full Case Study to learn how CliniSys is using the Rhapsody Integration Engine: